Kuwait Biobank Market Size & Outlook, 2023-2030
Kuwait biobank market, 2018-2030 (US$M)
Related Markets
Kuwait biobank market highlights
- The Kuwait biobank market generated a revenue of USD 160.9 million in 2023 and is expected to reach USD 234.3 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 5.5% from 2024 to 2030.
- In terms of segment, biobanking equipment was the largest revenue generating product in 2023.
- LIMS is the most lucrative product segment registering the fastest growth during the forecast period.
Biobank market data book summary
| Market revenue in 2023 | USD 160.9 million |
| Market revenue in 2030 | USD 234.3 million |
| Growth rate | 5.5% (CAGR from 2023 to 2030) |
| Largest segment | Biobanking equipment |
| Fastest growing segment | LIMS |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biobanking Equipment, Biobanking Consumables, LIMS |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Qiagen NV, Booz Allen Hamilton Holding Corp Class A, Tecan Group AG, Danaher Corp, Becton Dickinson & Co, Taylor-Wharton, Charles River Laboratories International Inc, Lonza Group Ltd, STEMCELL Technologies, PromoCell GmbH |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.2% of the global biobank market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa biobank market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 425.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biobank Market Scope
Biobank Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Kuwait biobank market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biobank market will help companies and investors design strategic landscapes.
Biobanking equipment was the largest segment with a revenue share of 73.71% in 2023. Horizon Databook has segmented the Kuwait biobank market based on biobanking equipment, biobanking consumables, lims covering the revenue growth of each sub-segment from 2018 to 2030.
Kuwait ranks 46th among the 51 high-income group economies and ranks 10th among the 19 economies in Northern Africa and Western Asia. The country is also a part of the Gulf Cooperation Council (GCC) and presents many opportunities for investments in the healthcare industry.
In addition, the country’s National Development Plan of USD 104 billion aims for major upgrades to Kuwait’s healthcare infrastructure and facilities.
The country is also home to the National Dasman Diabetes Biobank (NDDB), which offers repository services for supporting research projects related to diabetes. Such institutions are expected to increase awareness about biobanking and its applications in the country.
Reasons to subscribe to Kuwait biobank market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Kuwait biobank market databook
-
Our clientele includes a mix of biobank market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait biobank market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait biobank market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Kuwait biobank market size, by product, 2018-2030 (US$M)
Kuwait Biobank Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
